Mark Eichner, Alain Schmid, and Michael Giacomazzi-Weissen

Burckhardt advises selling shareholders in MIAC acquisition by Siena Imaging

Burckhardt advised the selling shareholders within the acquisition of MIAC, a Swiss clinical research company, by Italian startup Siena Imaging, which acquired 100% of MIAC’s shares.

MIAC

MIAC was a research-associated institution of the Universitätsspital Basel (USB). With its innovative and educational approach to clinical research, the Swiss company’s interests spanned over a plethora of activities, including radiological evaluations of various organ systems, validations of new examination methods, clinical data- management across all research phases, as well as second opinion assessments in the field of neuro-radiology.

The company was particularly renowned for its expertise in multiple sclerosis and other degenerative diseases.

Burckhardt’s team

Burckhardt, a Swiss law firm specialising in data protection, contract law, art law, M&A, and start-ups, served as legal advisor to the selling shareholders, overseeing all Swiss legal aspects of the transaction. The team included Mark Eichner, Alain Schmid, and Michael Giacomazzi-Weissen, all corporate and M&A.

PwC advised Siena Imaging over the reported transaction.

For more insights on the buyer side’s legal team, visit https://legalcommunity.it/pwc-tls-con-siena-imaging-nellacquisizione-della-svizzera-miac/

Pictured from left to right: Mark Eichner, Michael Giacomazzi-Weissen, and Alain Schmid.

flavio.caci@lcpublishinggroup.com

SHARE